CONVERGING ON CANCER @TUFTS
  • Home
  • About Us
  • Research Areas
  • Events
  • Home
  • About Us
  • Research Areas
  • Events
Search

We are a community of  interdisciplinary researchers and clinicians at Tufts University working to tackle cancer.

Upcoming event: Fall 2024 Symposium  
Friday November 1st, Breed Hall, 51 Winthrop St, Medford Campus 9-4pm
​Register here:

www.eventbrite.com/e/converging-on-cancer-at-tufts-2024-tickets-1031113075967?aff=oddtdtcreator
​Submit for a poster presentation here.
PROGRAM

9:00 – Welcome
 
9:10 – Dr. Sarah Hengel (BIO) - RAD51 paralogs in endometrial/ovarian cancers

9:30 – Dr.Chris Wiley (HNRNCA) - Cellular Senescence and ferroptosis as one-two-punch for cancer therapy
 
9:50 – Hanan Bloomer - Oudin lab (BME) - Dissecting the role of nerve-tumor crosstalk in breast cancer
 
10:10 – Dr. Dominique Michaud (Public Health) - DNA methylation patterns and cancer risk: an opportunity to better understand cancer etiology and identify high-risk individuals 
 
10:30 – Coffee break 
 
10:45 – Dr. Richard Travers (Jaffe Lab, MCRI) ‘Understanding the Vascular Toxicity of BCR-ABL Tyrosine Kinase Inhibitors)
 
11:05 – Dr. Elizabeth White (DMCB) - Papillomavirus oncoproteins reprogram host cell fate
 
11:25 – Dr. Isaac Gendelman, Schnelldorfer lab (Surgery) - What does cancer look like? A Report from the Surgical Imaging Lab 
 
11:45 – Dr. Nate Richbourg, Peyton lab (BME) - Modeling environmental triggers of breast cancer dormancy and reawakening
 
12:05 – Dr. Heather Gardner (Vet School) - Multi-omic tissue and plasma assessment to identify biomarkers of disease progression in osteosarcoma
 
12:25 – Lunch - light refreshments will be served
 
1-2PM – Poster session 
 
2:00 – Dr. Joshua Kritzer (CHEM) - Controlling Autophagy for Cancer Therapy and Targeted Protein Degradation
 
2:20 - Dr. Jaye Gardiner (BIO) - Role of the BAF Complex in Pancreatic Cancer-Associated Fibroblast Function
 
2:40 – Dr. Karl Munger lab (DMCB)- Non-protein targets and Effects of HPV Oncoproteins 
 
3:00 – Dr. Juanita Matthews (BIO) -Ion channel drugs suppress cancer phenotype in glioblastoma
 
3:20 – Dr. Gat Rauner (GMCB)- Engineering Organoid Models to Study Breast Cancer
 
3:40 – Dr. Srivalleesha Mallidi (BME) - Utility of oxygenated nanodroplets and ultrasound-guided photoacoustic imaging for cancer therapy



​POSTERS

  1. Marzieh Naseri, Moore lab, Boston Health Sciences Campus Targeting the mRNA 3’ end processing endonuclease, CPSF37: a novel approach to impeded the invasiveness of cancer cells 
  2. Crystal Zhang, Oudin lab, Department of Biomedical Engineering,  Role of the Resting Membrane Potential in Triple Negative Breast Cancer Metastasis
  3. Abigail Lebovitz and Tamara Vesel, Division of Palliative Care, Tufts Medical Center, Use of Ketamine for Cancer Related Pain in the Ambulatory Setting
  4. Meadow Parrish, Kuperwasser lab, Boston Health Sciences Campus, Exploring the effects of endocrine disruption + DNA damage on breast development and carcinogenic potential
  5. Ana Dias, McVey Lab, Department of Biology, Genetic Screening Reveals Critical Roles for Drosophila melanogaster Polymerase Eta and CG7139 in DNA Alkylation Damage Tolerance
  6. Artem Arkhangelskiy, Kaplan lab, Department of Biomedical Engineering, Electric and Magnetic Fields Therapy for Glioblastoma Multiforme: Tumor Treating Fields Approach
  7. Maya Gelbard, Munger lab, Boston Health Sciences Campus, Investigating the biochemical targets and biological activities of the HPV101 E7 protein
  8. Ivy Le, Van Deventer lab, Department of Chemical and Biological Engineering, Exploring Irreversible Protease Inhibition: Using Yeast Surface Display and Genetic Code Expansion to Engineer Covalent MMP-9 Inhibitors
  9. Michael Rist, Coffin lab, Boston Health Sciences Campus, Ex vivo HIV DNA integration in STAT3 drives T cell persistence—A model of HIV-associated T cell lymphoma
  10. Anna Yui, Oudin lab, Department of Biomedical Engineering,  Chemotherapy directly drives fibroblast activation and increased ECM production to drive invasion and recurrence in breast cancer
  11. Clara Fritz, Mendez lab, Boston Health Sciences Campus,  Unraveling the Assembly and Localization of Kaposi Sarcoma Associated Herpes Virus Primosome Complex
  12. Mili Das, Freudenreich lab, Department of Biology, DNA polymerase zeta can replicate through structures formed by AT repeat sequences and prevent their deletion
  13. Kerstin Seidel, Gardner lab, Tufts Vet School, Characterizing mutations of the histone methyltransferase SETD2 in canine osteosarcoma
  14. Brent Cochran, Boston Health Sciences Campus, Modeling glioblastoma stem cell heterogeneity with a dynamic causal model of the cell signaling network
  15. Srimoyee Mukherjee, Moore lab, Boston Health Sciences Campus, Alternative Polyadenylation Regulator CFIm25 Drives M1 Macrophage Polarization via AKT2 Modulation
Powered by Create your own unique website with customizable templates.
  • Home
  • About Us
  • Research Areas
  • Events